Your search for non small cell lung cancer returned 24 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mpr-drug-news remove
Brian Park, PharmD remove
Drugs in the Pipeline remove

Your search for non small cell lung cancer returned 24 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Cemiplimab Granted Priority Review for Advanced NSCLC

Topline results from the trial showed that compared with chemotherapy, treatment with cemiplimab-rwlc reduced the risk of death by 32% in the overall trial population.
Drugs in the Pipeline

Cemiplimab NSCLC Trial Stopped Early After Demonstrating Survival Benefit

Sanofi and Regeneron announced that the phase 3 trial evaluating cemiplimab (Libtayo®) as a potential first-line treatment in patients with locally advanced or metastatic non-small cell lung cancer was stopped early due to “highly significant improvement” in overall survival.